Blood management after bilateral total knee arthroplasty

Clinical Orthopaedics and Related Research

Volumn 410, Issue , 2003, Pages 254-261

  Bottner, Friedrich ^b   Pavone, Vito ^b   Johnson, Timothy ^b   Heitkemper, Sven ^b   Sculco, Thomas P ^a  

^a HOSPITAL FOR SPECIAL SURGERY   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN;

ADULT; AGED; ARTICLE; BLOOD ANALYSIS; BLOOD AUTOTRANSFUSION; BLOOD DONOR; BLOOD TRANSFUSION; FEMALE; HEALTH CARE COST; HEALTH CARE MANAGEMENT; HEMATOCRIT; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; PERIOPERATIVE PERIOD; POSTOPERATIVE CARE; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PREOPERATIVE PERIOD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; STATISTICAL ANALYSIS; TOTAL KNEE REPLACEMENT; TREATMENT INDICATION; WOUND DRAINAGE;

EID: 0038405127     PISSN: 0009921X     EISSN: 15281132     Source Type: Journal    
DOI: 10.1097/01.blo.0000063787.32430.6b     Document Type: Article

References (25)

1. American College of Physicians: Practice strategies for elective red blood cell transfusion. Ann Intern Med 116:403-406, 1992.
2. American Society of Anesthesiology: Practice guidelines for blood component therapy: A report by the American Society of Anesthesiologists task force on blood component therapy. Anesthesiology 84:732-747, 1996.
3. Anderson HT, Kessinger JM, McFarland Jr WJ, Laks H, Geha AS: Response of the hypertrophied heart to acute anemia and coronary stenosis. Surgery 84:8-15, 1978.
4. Arnestad JP, Hyllner M, Bengtson JP, et al: Removal of activated complement from shed blood: Comparison of high- and low-dilutional haemofiltration. Acta Anaesthesiol Scand 42:811-815, 1998.
5. Biesma DH, van Iperen CE, Kraaijenhagen RJ, et al: Red blood cell transfusions for total hip replacement in a regional hospital: A six-year analysis. Vox Sang 66:270-275, 1994.
6. Canadian Orthopedic Perioperative Erythropoietin Study Group: Effectiveness of perioperative recombinant human erythropoietin in elective hip replacement. Lancet 341:1227-1232, 1993.
7. Churchill WH, Chapman RH, Rutherford CJ, et al: Blood product utilization in hip and knee arthroplasty: Effect of gender and autologous blood on transfusion practice. Vox Sang 66:182-187, 1994.
8. Clements DH, Sculco TP, Burke SW, Mayer K, Levine DB: Salvage and reinfusion of postoperative sanguineous wound drainage: A preliminary report. J Bone Joint Surg 74A:646-651, 1992.
9. Consensus Development Conference: Perioperative red blood cell transfusion. JAMA 260:2700-2703, 1988.
10. De Andrade JR, Jove M, Landon G, et al: Baseline hemoglobin as a predictor of risk of transfusion and response to epoietin alpha in orthopedic surgery patients. Am J Orthop 25:533-542, 1996.
11. Dripps RD: New classification of physical status. Anesthesiology 24:111, 1963.
12. Etchason J, Petz L, Keeler E, et al: The cost effectiveness of preoperative autologous blood donations. N Engl J Med 332:719-724, 1995.
13. Faris PM, Ritter MA, Abels RI: The effects of recombinant human erythropoietin on perioperative transfusion requirements in patients having a major orthopaedic operation: The American Erythropoietin Study Group. J Bone Joint Surg 78A:62-72, 1996.
14. Jankiewicz JJ, Sculco TP, Ranawat CS, Behr C, Tarrentino S: One-stage versus 2-stage bilateral total knee arthroplasty. Clin Orthop 309:94-101, 1994.
15. Knight JL, Sherer D, Guo J: Blood transfusion strategies for total knee arthroplasty: Minimizing autologous blood wastage, risk of homologous blood transfusion, and transfusion cost. J Arthroplasty 13:70-76, 1998.
16. Lane GJ, Hozack WJ, Shah S, et al: Simultaneous bilateral versus unilateral total knee arthroplasty: Outcomes analysis. Clin Orthop 345:106-112, 1997.
17. Larocque B, Brien WF, Gilbert K: The utility and prediction of allogeneic blood transfusion use in orthopedic surgery. Transfus Med Rev 13:124-131, 1999.
18. Marsch SC, Schaefer HG, Skarvan K, Castelli I, Scheidegger D: Perioperative myocardial ischemia in patients undergoing elective hip arthroplasty during lumbar regional anesthesia. Anesthesiology 76:518-527, 1992.
19. McLaughlin TP, Fisher RL: Bilateral total knee arthroplasty: Comparison of simultaneous (two-team), sequential, and staged knee replacement. Clin Orthop 199:220-225, 1985.
20. Morrey BF, Adam RA, Ilstrup DM, Bryan RS: Complications and mortality associated with bilateral or unilateral total knee arthroplasty. J Bone Joint Surg 69A:484-488, 1987.
21. Nuttall GA, Santrach PJ, Oliver Jr WC, et al: The predictors of red blood cell transfusions in total hip arthroplasties. Transfusion 36:144-149, 1996.
22. Sehat KR, Evans R, Newman JH: How much blood is really lost in total knee arthroplasty? Correct blood loss management should take hidden loss into account. Knee 7:151-155, 2000.
23. Weiskopf RB, Viele MK, Feiner J, et al: Human cardiovascular and metabolic response to acute, severe isovolemic anemia. JAMA 279:217-221, 1998.
24. Welch HG, Meehan KR, Goodnough LT: Prudent strategies for elective red blood cell transfusion. Ann Intern Med 116:393-402, 1992.
25. Worland RL, Jessup DE, Clelland C: Simultaneous bilateral total knee replacement versus unilateral replacement. Am J Orthop 25:292-295, 1996.